Shopping Cart 0
Cart Subtotal
USD 0

VBI Vaccines Inc (VBV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

VBI Vaccines Inc (VBI), a subsidiary of SciVac Therapeutics Inc is a biopharmaceutical company that discovers and develops novel vaccines for the treatment of immuno-oncology and infectious diseases. The company's pipeline vaccine candidates include cytomegalovirus; glioblastoma multiforme and zika virus. It utilizes technologies such as eVLP platform, and thermostable platform to develop the vaccine candidates. VBI offers Sci-B-Vac, a hepatitis B vaccine which consists of surface antigens of hepatitis B virus and is free of any next-generation adjuvant. The company operates through its research facilities located in Ottawa, Canada; and a manufacturing facility in Rehovot, Israel. VBI is headquartered in Cambridge, Massachusetts, the US.

VBI Vaccines Inc (VBV)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

VBI Vaccines Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

VBI Vaccines Inc, Medical Devices Deals, 2012 to YTD 2018 10

VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deal Details 13

Venture Financing 13

Variation Biotech Raises USD 1.5 Million In Venture Financing 13

Variation Biotech Raised USD 1.4 Million In Venture Financing 14

Variation Biotech Raises USD 0.25 Million In Venture Financing 15

Variation Biotech Raises USD 0.8 Million In Venture Financing 16

Variation Biotech Raises Additional USD 1.2 Million In Venture Financing 17

VBI Vaccines Inc-Key Employees 19

VBI Vaccines Inc-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Recent Developments 21

Financial Announcements 21

Jul 26, 2018: VBI Vaccines Announces Second Quarter 2018 Financial Results and Provides Corporate Update 21

May 01, 2018: VBI Vaccines Reports First Quarter 2018 Financial Results 23

Corporate Communications 25

Sep 26, 2018: VBI Vaccines announces formation of new scientific and clinical advisory boards 25

Aug 15, 2018: VBI Vaccines appoints Christopher McNulty as chief financial officer and head of business development 27

Mar 12, 2018: VBI Vaccines Announces Voluntary Delisting from the Toronto Stock Exchange 28

Jan 26, 2018: VBI Vaccines Announces Changes to its Board of Directors 29

Nov 02, 2017: VBI Vaccines Strengthens Board of Directors with Appointment of Ran Nussbaum 30

Government and Public Interest 31

May 31, 2017: Researchers Explore the Possible Link between CMV Infection, Obesity, and Metabolic Syndrome 31

Product News 32

11/10/2017: VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at SITC 2017 32

04/17/2018: VBI Vaccines Announces Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients 33

04/05/2017: VBI Vaccines to Present Update on VBI-1901 at the World Vaccine Congress 34

02/07/2017: VBI Vaccines Receives Positive EMA Scientific Advice Regarding Sci-B-Vac Phase III Clinical Study 35

01/17/2018: VBI Vaccines Announces Dosing of First GBM Patient in Phase 1/2a Clinical Study of VBI-1901 36

Product Approvals 37

Aug 15, 2017: VBI Vaccines Announces FDA Acceptance of Investigational New Drug Application for VBI-1901 to Treat Glioblastoma Multiforme 37

Clinical Trials 38

Oct 11, 2017: VBI Vaccines to Present Phase 1 CMV vaccine data at The World Vaccine Congress Europe 2017 in Barcelona 38

Oct 11, 2017: VBI Vaccines to Present preclinical Zika vaccine data at The World Vaccine Congress Europe 2017 in Barcelona 39

Aug 28, 2017: VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at The Immuno-Oncology Summit 40

Jul 27, 2017: VBI Vaccines Announces Positive Interim Data from Phase 1 Study of Preventative CMV Vaccine 41

May 02, 2017: VBI Vaccines Provides Update on its Congenital CMV Phase I Clinical Study 42

Feb 22, 2017: VBI Vaccines Receives Positive Response from Health Canada's Initial Evaluation of the Proposed Sci-B-Vac Phase III Clinical Program 43

Appendix 44

Methodology 44

About GlobalData 44

Contact Us 44

Disclaimer 44


List Of Figure

List of Figures

VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

VBI Vaccines Inc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

VBI Vaccines Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

VBI Vaccines Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

VBI Vaccines Inc, Deals By Therapy Area, 2012 to YTD 2018 9

VBI Vaccines Inc, Medical Devices Deals, 2012 to YTD 2018 10

VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Variation Biotech Raises USD 1.5 Million In Venture Financing 13

Variation Biotech Raised USD 1.4 Million In Venture Financing 14

Variation Biotech Raises USD 0.25 Million In Venture Financing 15

Variation Biotech Raises USD 0.8 Million In Venture Financing 16

Variation Biotech Raises Additional USD 1.2 Million In Venture Financing 17

VBI Vaccines Inc, Key Competitors 18

VBI Vaccines Inc, Key Employees 19

VBI Vaccines Inc, Other Locations 20

VBI Vaccines Inc, Subsidiaries 20

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

VBI Vaccines Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.